Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Vasile Musteata"'
Autor:
Vasile Musteata
Publikováno v:
HemaSphere, Vol 7, p e3418744 (2023)
Externí odkaz:
https://doaj.org/article/504ddb2d6d1a41eb96bfd681c3039d8b
Autor:
Vasile MUSTEATA
Publikováno v:
Archives of the Balkan Medical Union, Vol 56, Iss 4, Pp 455-460 (2021)
Introduction. A growing number of studies indicates the increased susceptibility of patients with hematologic malignancies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as compared to the apparently healthy population. Th
Externí odkaz:
https://doaj.org/article/1c614a78154e420abc1da5265defd652
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S21- (2022)
Objective: Theaim of the study was to identify the diagnosis features and origin of the infectious complications in chronic lymphocytic leukemia (CLL). Methodology: Our observational study enrolled 82 patients (pts) with different CLL phases, who wer
Externí odkaz:
https://doaj.org/article/a74d12be2a414fc38c8277d2f9c6a6fe
Autor:
Vasile Musteata
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S28- (2022)
Objective: The study objective was to analyze the short- and long-term results of treatment discontinuation in patients with chronic myeloid leukemia (CML) and complete molecular response (CMR). Methodology: This prospective study enrolled 22 patient
Externí odkaz:
https://doaj.org/article/0c13f53c7e04456da098e05d3f8eaff2
Publikováno v:
The Moldovan Medical Journal, Vol 63, Iss 6, Pp 12-15 (2020)
Background: Chronic myeloproliferative hemopathies (CMPH) as a whole are the most common chronic leukemias in the elderly in the structure of morbidity by hematological malignancies with primary bone marrow involvement, being characterized in the adv
Externí odkaz:
https://doaj.org/article/e436097af35f409fb23247a751068bfc
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S15-S16 (2021)
Objective: The increased morbidity and DALY rates in the working-age population, commonly late diagnosis and unfavorable socio-economic impact of non-Hodgkin lymphomas (NHL) can be considered as key issues of hemato-oncology. Clinico-hematological pa
Externí odkaz:
https://doaj.org/article/9868fe7020f5499bb9931c2512380d30
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S45- (2021)
Objective: The advanced stages of multiple myeloma (MM) commonly manifest a recurrent evolution, unfavorable prognosis and negative socio-economic impact. The increased rates of morbidity and DALYs, frequent complications and relapses, unfavorable so
Externí odkaz:
https://doaj.org/article/3b8cb8fbe8504e4fb873f07df2cb2562
Autor:
Adrian, Nitrean1, Vasile, Musteata2,3
Publikováno v:
German International Journal of Modern Science / Deutsche Internationale Zeitschrift für Zeitgenössische Wissenschaft. Apr2023, Issue 54, p40-45. 6p.
Autor:
Vasile Musteata
Publikováno v:
International Journal of Clinical Medicine. 14:206-215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e3b320edce23a33333dad1c0e4cacbb
https://doi.org/10.4236/ijcm.2023.144016
https://doi.org/10.4236/ijcm.2023.144016
Autor:
Vasile Musteata
Publikováno v:
International Journal of Clinical Medicine. 14:79-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57484ba6b02a7d548d21d5d872c3780c
https://doi.org/10.4236/ijcm.2023.142006
https://doi.org/10.4236/ijcm.2023.142006